{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:49:45Z","timestamp":1794383385610,"version":"4.9.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05085-w","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T05:59:05Z","timestamp":1759989545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["10-year follow-up of patients treated with catheter-based renal denervation for resistant hypertension: an observational study"],"prefix":"10.1186","volume":"25","author":[{"given":"Thomas Maria","family":"Melchior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Kelb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Hecht","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Emil","family":"Melchior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Munch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Kj\u00f8ller-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"38","key":"5085_CR1","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, Christodorescu RM, Daskalopoulou SS, Ferro CJ, et al. 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912\u20134018. https:\/\/doi.org\/10.1093\/eurheartj\/ehae178.","journal-title":"Eur Heart J"},{"issue":"10","key":"5085_CR2","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1161\/HYP.0000000000000240","volume":"81","author":"JL Cluett","year":"2024","unstructured":"Cluett JL, Blazek O, Brown AL, East C, Ferdinand KC, Fisher NDL, Ford CD, Griffin KA, Mena-Hurtado CI, et al. Renal denervation for the treatment of hypertension: a scientific statement from the American Heart Association. Hypertension. 2024;81(10):e135\u201348.","journal-title":"Hypertension"},{"key":"5085_CR3","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/S0140-6736(18)30951-6","volume":"391","author":"DE Kandzari","year":"2018","unstructured":"Kandzari DE, B\u00f6hm M, Mahfoud F, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomized trial. Lancet. 2018;391:2346\u201355.","journal-title":"Lancet"},{"key":"5085_CR4","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/S0140-6736(20)30554-7","volume":"395","author":"M B\u00f6hm","year":"2020","unstructured":"B\u00f6hm M, Kario K, Kandzari DE, Mahfoud F, Weber MA, Schmieder RE, Tsioufis K, Pocock S, Konstantinidis D, Choi JW, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet. 2020;395:1444\u201351. https:\/\/doi.org\/10.1016\/S0140-6736(20)30554-7.","journal-title":"Lancet"},{"key":"5085_CR5","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/S0140-6736(18)31082-1","volume":"391","author":"M Azizi","year":"2018","unstructured":"Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, Basile J, Kirtane AJ, Wang Y, Lobo MD, et al. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet. 2018;391:2335\u201345. https:\/\/doi.org\/10.1016\/S0140-6736(18)31082-1.","journal-title":"Lancet"},{"key":"5085_CR6","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0140-6736(22)01787-1","volume":"400","author":"DL Bhatt","year":"2022","unstructured":"Bhatt DL, Vaduganathan M, Kandzari DE, Leon MB, Rocha-Singh K, Townsend RR, Katzen BT, Oparil S, Brar S, DeBruin V, Fahy M, Bakris GL, SYMPLICITY HTN-3 Steering Committee Investigators. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomized SYMPLICITY HTN-3 trial. Lancet. 2022;400:1405\u201316.","journal-title":"Lancet"},{"key":"5085_CR7","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s41440-022-00910-7","volume":"45","author":"P Pariya Panchavinnin","year":"2022","unstructured":"Pariya Panchavinnin P, Wanthong S, Roubsanthisuk W, et al. Long-term outcome of renal nerve denervation (RDN) for resistant hypertension. Hypertens Res. 2022;45:962\u20136.","journal-title":"Hypertens Res"},{"key":"5085_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1161\/HYPERTENSIONAHA.122.20853","volume":"80","author":"G Sesa-Ashton","year":"2023","unstructured":"Sesa-Ashton G, Nolde JN, Muente I, et al. Catheter-based renal denervation: 9-year follow-up data on safety and blood pressure reduction in patients with resistant hypertension. Hypertension. 2023;80:811\u20139.","journal-title":"Hypertension"},{"key":"5085_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jacc.2022.11.038","volume":"81","author":"H Al Ghorani","year":"2023","unstructured":"Al Ghorani H, Kulenthiran S, Recktenwald MJM, Lauder L, Kunz M, G\u00f6tzinger F, et al. 10-year outcomes of catheter-based renal denervation in patients with resistant hypertension. J Am Coll Cardiol. 2023;81:517\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"5085_CR10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/HJH.0000000000003650","volume":"42","author":"L Wang","year":"2024","unstructured":"Wang L, Li C, Li Z, Li Q, Liu C, Sun X, He Q, Xia DS, Xia D, Lu C. Ten-year follow-up of very-high risk hypertensive patients undergoing renal sympathetic denervation. J Hypertens. 2024;42(5):801\u20138. https:\/\/doi.org\/10.1097\/HJH.0000000000003650.","journal-title":"J Hypertens"},{"key":"5085_CR11","doi-asserted-by":"publisher","first-page":"e467","DOI":"10.4244\/EIJ-D-23-00836","volume":"20","author":"L Lauder","year":"2024","unstructured":"Lauder L, Kandzari DE, L\u00fcscher TF, Mahfoud F. Renal denervation in the management of hypertension. EuroIntervention. 2024;20:e467\u201378.","journal-title":"EuroIntervention"},{"key":"5085_CR12","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","volume":"397","author":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","year":"2021","unstructured":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021;397:1625\u201336.","journal-title":"Lancet"},{"issue":"10305","key":"5085_CR13","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S0140-6736(21)01921-8","volume":"398","author":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","year":"2021","unstructured":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis. Lancet. 2021;398(10305):1053\u201364.","journal-title":"Lancet"},{"issue":"9","key":"5085_CR14","first-page":"645","volume":"10","author":"M Nazarzadeh","year":"2022","unstructured":"Nazarzadeh M, Bidel Z, Canoy C, et al. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis. Lancet. 2022;10(9):645\u201354.","journal-title":"Lancet"},{"key":"5085_CR15","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology.\u00a0Guidelines for ATC classification and DDD assignment, 2025. Oslo; 2025. https:\/\/atcddd.fhi.no\/atc_ddd_index_and_guidelines\/guidelines\/. https:\/\/atcddd.fhi.no\/atc_ddd_index\/."},{"key":"5085_CR16","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/S0140-6736(17)32281-X","volume":"390","author":"RR Townsend","year":"2017","unstructured":"Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, Ewen S, Tsioufis K, Tousoulis D, Sharp ASP, et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017;390:2160\u201370. https:\/\/doi.org\/10.1016\/S0140-6736(17)32281-X.","journal-title":"Lancet"},{"key":"5085_CR17","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1001\/jama.2023.0713","volume":"329","author":"M Azizi","year":"2023","unstructured":"Azizi M, Saxena M, Wang Y, Jenkins JS, Devireddy C, Rader F, Fisher NDL, Schmieder RE, Mahfoud F, Lindsey J, et al. Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial. JAMA. 2023;329:651\u201361. https:\/\/doi.org\/10.1001\/jama.2023.0713.","journal-title":"JAMA"},{"issue":"4","key":"5085_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/eurheartj\/ehu441","volume":"36","author":"DE Kandzari","year":"2015","unstructured":"Kandzari DE, Bhatt DL, Brar S, Devireddy CM, Esler M, Fahy M, Flack JM, Katzen BT, Lea J, Lee DP, Leon MB, Ma A, Massaro J, Mauri L, Oparil S, O\u2019Neill WW, Patel MR, Rocha-Singh K, Sobotka PA, Svetkey L, Townsend RR, Bakris GL. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J. 2015;36(4):219\u201327. https:\/\/doi.org\/10.1093\/eurheartj\/ehu441.","journal-title":"Eur Heart J"},{"issue":"1","key":"5085_CR19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1161\/01.cir.96.1.308","volume":"96","author":"SS Franklin","year":"1997","unstructured":"Franklin SS, Gustin W4th, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure. Circulation. 1997;96(1):308\u201315. https:\/\/doi.org\/10.1161\/01.cir.96.1.308.","journal-title":"Circulation"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05085-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05085-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05085-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T05:59:06Z","timestamp":1759989546000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-05085-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5085"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05085-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RDN treatment was implemented as a routine treatment option in Denmark in 2011\u201312 for patients with treatment-resistant hypertension. All patients were thoroughly instructed and gave informed consent for RDN treatment in accordance with the Declaration of Helsinki. The current data were collected as part of a national report (Medical Technology Assessment (MTA), and all patient-identifiable fields were removed before analysis. According to our local authorities, such a report did not require approval by our ethics committee. Data are placed on a secure server in accordance with GDPR (General Data Protection Regulation) legislation applicable in Denmark.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"723"}}